Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 25, 2018 16:05 ET | Source: IMV Inc.

IMV (Formerly Immunovaccine Inc.) to Present at the National Bank Financial Quebec Conference in Toronto

HALIFAX, Nova Scotia, May 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that IMV Chief Executive Officer Frederic Ors will...
May 14, 2018 16:35 ET | Source: IMV Inc.

IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results

HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVD), a clinical stage immuno-oncology corporation, today released its financial and operational results for the...
May 10, 2018 10:29 ET | Source: IMV Inc.

IMV Inc. – Change of ticker on OTCQX from IMMVF to IMMVD

HALIFAX, Nova Scotia, May 10, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (TSX:IMV) (OTCQX:IMMVD), a clinical stage immunotherapy company, announced that its new ticker on OTCQX...
May 10, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. Commences Trading on the TSX and OTCQX Post-Reverse Stock Split

HALIFAX, Nova Scotia, May 10, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (TSX:IMV) (OTCQX:IMMVF), a clinical stage immunotherapy company, announced that its common shares...
May 03, 2018 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Inc. Has Applied to List its Common Shares on Nasdaq, Announces Reverse Stock Split

HALIFAX, Nova Scotia, May 03, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Corporation”) (TSX:IMV) (OTCQX:IMMVF), a clinical stage immunotherapy company, announced today that...
May 01, 2018 16:35 ET | Source: Immunovaccine Inc.

Immunovaccine Shareholders Approve Share Consolidation at 99.85%

HALIFAX, Nova Scotia, May 01, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today announced that at the annual and special meeting...
April 26, 2018 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Highlight Clinical Data for Its Lead Candidate in Oral Presentation at 54th Annual Meeting of the American Society of Clinical Oncology

HALIFAX, Nova Scotia, April 26, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that its abstract has been selected for...
April 24, 2018 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer

HALIFAX, Nova Scotia, April 24, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has entered into an agreement...
April 23, 2018 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference

HALIFAX, Nova Scotia, April 23, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced that Chief Executive Officer Frederic Ors...
April 17, 2018 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Leading Independent Proxy Advisory Firms Recommend Voting for Share Consolidation Related to Potential Nasdaq Listing

HALIFAX, Nova Scotia, April 17, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, is pleased to announce that Institutional...